Latest Filings

Issuer Activity

Insider Overview :: Lorus Therapeutics Inc. (T:LOR) [?]
Business Focus: Biotechnology & Medical Research
Recent Price for LOR
CAD 0.200 0.00 (0.00%)
TSX Delayed 15 minutes
May 23 1523 EDT
1-Day High 52-Week High P/E 1-Day Volume Mkt Cap ($Mil)
N/A 0.640 0.0 N/A 8.45
1-Day Low 52-Week Low Yield Avg. Volume  
N/A 0.190 0.0% 20,433  
Log in or sign up for a free account to add this stock to your watch list.

Holdings trends & enhanced charts available in PDF report. Click here for details »
Latest 10 SEDI filings (by transaction date) for LOR within the last 6 months [?]
Amended Filing
As of 11:59pm ET May 23rd, 2013
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
No SEDI filings within the past 6 months or filings data currently unavailable.
Sign up for an account or login above to see all SEDI filings within the past 6 months.
Latest 10 SEDI filings (by filing date) for LOR within the last 6 months [?]
Amended Filing
As of 11:59pm ET May 23rd, 2013
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
No SEDI filings within the past 6 months or filings data currently unavailable.
Sign up for an account or login above to see all SEDI filings within the past 6 months.
Sign up for an account or login above to see the past 6 months of SEDI filings sorted by insider.
No Markers (TSX Insider Summaries) for LOR on May 23, 2013 [?]
To view marker data for the past week, sign up for an account or log in above.
To view more history, sign up for an account at inkresearch.com
Sector:  Healthcare Industry:  Biotechnology & Medical Research
Key People
Jim A. Wright
Chairman of the Board
Aiping H. Young
President, Chief Executive Officer, Director
Elizabeth Williams
Acting Chief Financial Officer, Director - Finance
Yoon Lee
Vice President - Research
   
Company Contact
Address: 2 Meridian Road
TORONTO ON M9W 4Z7
Tel: 1-514-9393989
Website: www.lorusthera.com
IR: www.lorusthera.com/investors/index.php
Business Overview
Lorus Therapeutics Inc. (Lorus) is a biopharmaceutical company. The Company is a discovery, research and clinical development-stage company with a focus on cancer drugs. The Company has an active portfolio, including small molecules (LOR-253/LOR-500) and an immunotherapy (IL-17E). Lorus has worked to establish a marketable anticancer product pipeline, with products in various stages of development ranging from discovery and pre-clinical to a product available to start a Phase III clinical trial. Lorus has one subsidiary, NuChem Pharmaceuticals Inc. (NuChem).
Competitors with Recent Insider Filings
QLT (T:QLT)
EnWave (V:ENW)
iCo Therapeutics (V:ICO)
 
Lorus Therapeutics Inc. Insider Report Only $20.00